with the invocell and invo procedure, invo bioscience allows more and more patients to now receive safe, effective and affordable infertility treatment.
Company profile
Ticker
INVO
Exchange
Website
CEO
Steven M. Shum
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
EMY'S SALSA AJI DISTRIBUTION COMPANY, INC.
SEC CIK
Corporate docs
Subsidiaries
Bio X Cell, Inc. • INVO Centers, LLC • Orange Blossom Fertility, LLC • Wood Violet Fertility, LLC ...
INVO stock data
Latest filings (excl ownership)
10-K/A
2022 FY
Annual report (amended)
27 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Other Events
1 Feb 24
S-4
Registration of securities issued in business combination transactions
16 Jan 24
8-K/A
Entry into a Material Definitive Agreement
10 Jan 24
8-K
Entry into a Material Definitive Agreement
10 Jan 24
8-K
Entry into a Material Definitive Agreement
3 Jan 24
424B7
Prospectus with selling stockholder info
28 Dec 23
8-K
Entry into a Material Definitive Agreement
28 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
27 Dec 23
Transcripts
INVO
Earnings call transcript
2023 Q2
14 Aug 23
INVO
Earnings call transcript
2023 Q1
15 May 23
INVO
Earnings call transcript
2022 Q4
17 Apr 23
INVO
Earnings call transcript
2022 Q3
15 Nov 22
INVO
Earnings call transcript
2022 Q2
16 Aug 22
INVO
Earnings call transcript
2022 Q1
17 May 22
INVO
Earnings call transcript
2021 Q4
1 Apr 22
INVO
Earnings call transcript
2021 Q3
16 Nov 21
INVO
Earnings call transcript
2021 Q2
17 Aug 21
INVO
Earnings call transcript
2021 Q1
18 May 21
Latest ownership filings
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
SC 13G/A
AWM Investment Company, Inc.
8 Sep 23
SC 13G
INTRACOASTAL CAPITAL, LLC
11 Aug 23
4
Matthew K Szot
22 May 23
4
Steve Shum
22 May 23
4
Barbara Ryan
22 May 23
4
Rebecca Messina
22 May 23
4
Andrea Goren
22 May 23
4
TRENT D DAVIS
22 May 23
4
Michael Jos. Campbell
22 May 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
38.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 3 |
Closed positions | 7 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 185.92 mm |
Total shares | 960.01 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
AWM Investment | 623.86 k | $127.27 mm |
Vanguard | 105.54 k | $21.13 mm |
Geode Capital Management | 87.19 k | $17.79 mm |
Two Sigma Securities | 28.55 k | $5.72 mm |
VIRT Virtu Financial | 24.05 k | $5.00 k |
STT State Street | 23.78 k | $4.85 mm |
Renaissance Technologies | 20.20 k | $4.00 k |
Advisor | 12.18 k | $2.44 mm |
NTRS Northern Trust | 11.41 k | $2.28 mm |
RY Royal Bank Of Canada | 10.77 k | $2.00 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 May 23 | Steve Shum | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 100,000 | 36.80 k | 100,000 |
18 May 23 | Szot Matthew K | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 85,000 | 31.28 k | 85,000 |
18 May 23 | Trent D Davis | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 85,000 | 31.28 k | 85,000 |
18 May 23 | Rebecca Messina | Stock Option Common Stock | Grant | Dispose A | No | No | 0.362 | 85,000 | 30.77 k | 85,000 |
18 May 23 | Michael Jos. Campbell | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 83,000 | 30.54 k | 83,000 |
News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
28 Mar 24
Naya Biosciences To Acquire Florida Biotechnologies For $20M Shares Of NAYA Post-Merger With INVO; Florida Biotechnologies Eligible For Additional $5M Upon Certain Milestones Achievement
23 Jan 24
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
23 Jan 24
12 Health Care Stocks Moving In Friday's Pre-Market Session
19 Jan 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Jan 24